Cerebral cortex structure in prodromal Huntington disease

Neurobiology of Disease

Volumn 40, Issue 3, 2010, Pages 544-554

  Nopoulos, Peggy C ^a   Aylward, Elizabeth H ^b   Ross, Christopher A ^c,d   Johnson, Hans J ^a   Magnotta, Vincent A ^a   Juhl, Andrew R ^a   Pierson, Ronald K ^a   Mills, James ^a   Langbehn, Douglas R ^a   Paulsen, Jane S ^a  

^a UNIVERSITY OF IOWA   (United States)

^b SEATTLE CHILDREN S RESEARCH INSTITUTE   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cerebral cortex; Cortical thickness; Huntington disease; MRI; Surface area

Indexed keywords

ADULT; ARTICLE; BRAIN CORTEX; BRAIN REGION; BRAIN SIZE; CAG REPEAT; CONTROLLED STUDY; CRANIOFACIAL MORPHOLOGY; FEMALE; FRONTAL LOBE; GENE MUTATION; HETEROZYGOTE DETECTION; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; PARIETAL LOBE; PRIORITY JOURNAL; PROGNOSIS; SKULL; TEMPORAL LOBE;

ADULT; CEREBRAL CORTEX; EARLY DIAGNOSIS; FEMALE; HUMANS; HUNTINGTON DISEASE; LONGITUDINAL STUDIES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED;

EID: 77957780179     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2010.07.014     Document Type: Article

References (57)

1. Abe O., Yamasue H., Aoki S., Suga M., Yamada H., Kasai K., et al. Aging in the CNS: comparison of gray/white matter volume and diffusion tensor data. Neurobiol. Aging 2008, 29(1):102-116.
2. Aylward, E.H., Nopoulos, P., Ross, C.A., Langbehn, D.R., Pierson, R., Mills, J., et al., forthcoming. Longitudinal change in regional brain volumes in preclinical Huntington disease. J. Neurol. Neurosurg. Psychiatry.
3. Aylward E.H., Anderson N.B., Bylsma F.W., Wagster M.V., Barta P.E., Sherr M., et al. Frontal lobe volume in patients with Huntington's disease. Neurology 1998, 50(1):252-258.
4. Bartzokis G., Lu P.H., Tishler T.A., Fong S.M., Oluwadara B., Finn J.P., et al. Myelin breakdown and iron changes in Huntington's disease: pathogenesis and treatment implications. Neurochem. Res. 2007, 32(10):1655-1664.
5. Bartzokis G., Lu P.H., Tishler T.A., Perlman S. In vivo assessment of iron in Huntington's disease and other age-related degenerative brain diseases. Metal Ions in life sciences 2006, 151-177. Wiley, Chichester. A. Sigel, H. Sigel, R.K.O. Sigel (Eds.).
6. Beglinger L.J., Nopoulos P.C., Jorge R.E., Langbehn D.R., Mikos A.E., Moser D.J., et al. White matter volume and cognitive dysfunction in early Huntington's disease. Cogn. Behav. Neurol. 2005, 18(2):102-107.
7. Ciarmiello A., Cannella M., Lastoria S., Simonelli M., Frati L., Rubinsztein D.C., et al. Brain white-matter volume loss and glucose hypometabolism precede the clinical symptoms of Huntington's disease. J. Nucl. Med. 2006, 47(2):215-222.
8. Dale A., Sereno M.I. Improved localization of cortical activity by combining EEG and MEG with MRI cortical surface reconstruction: a linear approach. J. Cogn. Neurosci. 1993, 5:162-176.
9. Dale A.M., Fischl B., Sereno M.I. Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 1999, 9(2):179-194.
10. Desikan R.S., Segonne F., Fischl B., Quinn B.T., Dickerson B.C., Blacker D., et al. An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 2006, 31(3):968-980.
11. DiProspero N.A., Chen E.Y., Charles V., Plomann M., Kordower J.H., Tagle D.A. Early changes in Huntington's disease patient brains involve alterations in cytoskeletal and synaptic elements. J. Neurocytol. 2004, 33(5):517-533.
12. Douaud G., Gaura V., Ribeiro M.J., Lethimonnier F., Maroy R., Verny C., et al. Distribution of grey matter atrophy in Huntington's disease patients: a combined ROI-based and voxel-based morphometric study. Neuroimage 2006, 32(4):1562-1575.
13. Fennema-Notestine C., Archibald S.L., Jacobson M.W., Corey-Bloom J., Paulsen J.S., Peavy G.M., et al. In vivo evidence of cerebellar atrophy and cerebral white matter loss in Huntington disease. Neurology 2004, 63(6):989-995.
14. Fischl B., Dale A.M. Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc. Natl. Acad. Sci. U. S. A. 2000, 97(20):11050-11055.
15. Fischl B., Liu A., Dale A.M. Automated manifold surgery: constructing geometrically accurate and topologically correct models of the human cerebral cortex. IEEE Trans. Med. Imaging 2001, 20(1):70-80.
16. Fischl B., Sereno M.I., Dale A.M. Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 1999, 9(2):195-207.
17. Fischl B., Sereno M.I., Tootell R.B., Dale A.M. High-resolution intersubject averaging and a coordinate system for the cortical surface. Hum. Brain Mapp. 1999, 8(4):272-284.
18. Fischl B., van der Kouwe A., Destrieux C., Halgren E., Segonne F., Salat D.H., et al. Automatically parcellating the human cerebral cortex. Cereb. Cortex 2004, 14(1):11-22.
19. Genovese C.R., Lazar N.A., Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002, 15(4):870-878.
20. Han X., Jovicich J., Salat D., van der Kouwe A., Quinn B., Czanner S., et al. Reliability of MRI-derived measurements of human cerebral cortical thickness: the effects of field strength, scanner upgrade and manufacturer. Neuroimage 2006, 32(1):180-194.
21. Harris G., Andreasen N.C., Cizadlo T., Bailey J.M., Bockholt H.J., Magnotta V.A., et al. Improving tissue segmentation in MRI: a three-dimensional multispectral discriminant analysis method with automated training class selection. J. Comput. Assist. Tomogr. 1999, 23:144-154.
22. Hedreen J.C., Peyser C.E., Folstein S.E., Ross C.A. Neuronal loss in layers V and VI of cerebral cortex in Huntington's disease. Neurosci. Lett. 1991, 133(2):257-261.
23. Heinsen H., Strik M., Bauer M., Luther K., Ulmar G., Gangnus D., et al. Cortical and striatal neurone number in Huntington's disease. Acta Neuropathol. (Berl). 1994, 88(4):320-333.
24. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72(6):971-983.
25. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov. Disord. 1996, 11(2):136-142. Huntington Study Group.
26. Jernigan T.L., Salmon D.P., Butters N., Hesselink J.R. Cerebral structure on MRI, Part II: Specific changes in Alzheimer's and Huntington's diseases. Biol. Psychiatry 1991, 29(1):68-81.
27. Kipps C.M., Duggins A.J., Mahant N., Gomes L., Ashburner J., McCusker E.A. Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. J. Neurol. Neurosurg. Psychiatry 2005, 76(5):650-655.
28. Kuperberg G.R., Broome M.R., McGuire P.K., David A.S., Eddy M., Ozawa F., et al. Regionally localized thinning of the cerebral cortex in schizophrenia. Arch. Gen. Psychiatry 2003, 60(9):878-888.
29. Langbehn D.R., Brinkman R.R., Falush D., Paulsen J.S., Hayden M.R. A new model for prediction of the age of onset and penetrance for Huntington's disease based on CAG length. Clin. Genet. 2004, 65(4):267-277.
30. Langbehn D.R., Hayden M.R., Paulsen J.S. CAG-repeat length and the age of onset in Huntington disease (HD): A review and validation study of statistical approaches. Am. J. Med. Genet. B 2009, 153B:397-408.
31. Lange H.W. Quantitative changes of telencephalon, diencephalon, and mesencephalon in Huntingon's chorea, postecephalitic, and adiopathic parkinsonism. Verh. Anat. Ges. 1981, 75:923-925.
32. Magnotta V., Harris G., Andreasen N.C., O'Leary D.S., Yuh W.T., Heckel D. Structural MR image processing using the BRAINS2 toolbox. Comput. Med. Imaging Graph. 2002, 26(4):251-264.
33. Middleton F.A., Strick P.L. Basal ganglia and cerebellar output influences non-motor function. Mol. Psychiatry 1996, 1(6):429-433.
34. Middleton F.A., Strick P.L. The temporal lobe is a target of output from the basal ganglia. Proc. Natl. Acad. Sci. U. S. A. 1996, 93(16):8683-8687.
35. Middleton F.A., Strick P.L. Basal ganglia and cerebellar loops: motor and cognitive circuits. Brain Res. Brain Res. Rev. 2000, 31(2-3):236-250.
36. Molero A.E., Gokhan S., Gonzalez S., Feig J.L., Alexandre L.C., Mehler M.F. Impairment of developmental stem cell-mediated striatal neurogenesis and pluripotency genes in a knock-in model of Huntington's disease. Proc. Natl. Acad. Sci. U. S. A. 2010, 106(51):21900-21905. 10.1073/pnas.0912171106.
37. Muhlau M., Weindl A., Wohlschlager A.M., Gaser C., Stadtler M., Valet M., et al. Voxel-based morphometry indicates relative preservation of the limbic prefrontal cortex in early Huntington disease. J. Neural. Transm. 2007, 114(3):367-372.
38. Nopoulos P., Magnotta V.A., Mikos A., Paulson H., Andreasen N.C., Paulsen J.S. Morphology of the cerebral cortex in preclinical Huntington's disease. Am. J. Psychiatry 2007, 164(9):1428-1434.
39. Panizzon M.S., Fennema-Notestine C., Eyler L.T., Jernigan T.L., Prom-Wormley E., Neale M., et al. Distinct genetic influences on cortical surface area and cortical thickness. Cereb. Cortex 2009, 19(11):2728-2735.
40. Paulsen J.S., Hayden M., Stout J.C., Langbehn D.R., Aylward E., Ross C.A., et al. Preparing for preventive clinical trials: the Predict-HD study. Arch. Neurol. 2006, 63(6):883-890.
41. Paulsen J.S., Langbehn D.R., Stout J.C., Aylward E., Ross C.A., Nance M., et al. Detection of Huntington's disease decades before diagnosis: the Predict-HD study. J. Neurol. Neurosurg. Psychiatry 2008, 79(8):874-880.
42. Paulsen J.S., Nopoulos P., Aylward E., Ross C.A., Johnson H., Magnotta V.A., et al. Striatal and white matter predictors of estimated diagnosis for Huntington disease. Brain Res. Bull. 2010, 82:201-207.
43. Paulsen J.S., Zimbelman J.L., Hinton S.C., Langbehn D.R., Leveroni C.L., Benjamin M.L., et al. An fMRI biomarker of early neuronal dysfunction in presymptomatic Huntington's disease. AJNR Am. J. Neuroradiol. 2004, 25(10):1715-1721.
44. Reading S.A., Dziorny A.C., Peroutka L.A., Schreiber M., Gourley L.M., Yallapragada V., et al. Functional brain changes in presymptomatic Huntington's disease. Ann. Neurol. 2004, 55(6):879-883.
45. Rosas H.D., Hevelone N.D., Zaleta A.K., Greve D.N., Salat D.H., Fischl B. Regional cortical thinning in preclinical Huntington disease and its relationship to cognition. Neurology 2005, 65(5):745-747.
46. Rosas H.D., Koroshetz W.J., Chen Y.I., Skeuse C., Vangel M., Cudkowicz M.E., et al. Evidence for more widespread cerebral pathology in early HD: an MRI-based morphometric analysis. Neurology 2003, 60(10):1615-1620.
47. Rosas H.D., Liu A.K., Hersch S., Glessner M., Ferrante R.J., Salat D.H., et al. Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002, 58(5):695-701.
48. Salat D.H., Buckner R.L., Snyder A.Z., Greve D.N., Desikan R.S., Busa E., et al. Thinning of the cerebral cortex in aging. Cereb. Cortex 2004, 14(7):721-730.
49. Segonne F., Dale A.M., Busa E., Glessner M., Salat D., Hahn H.K., et al. A hybrid approach to the skull stripping problem in MRI. Neuroimage 2004, 22(3):1060-1075.
50. Segonne F., Pacheco J., Fischl B. Geometrically accurate topology-correction of cortical surfaces using nonseparating loops. IEEE Trans. Med. Imaging 2007, 26(4):518-529.
51. Selemon L.D., Rajkowska G., Goldman-Rakic P.S. Evidence for progression in frontal cortical pathology in late-stage Huntington's disease. J. Comp. Neurol. 2004, 468(2):190-204.
52. Sotrel A., Paskevich P.A., Kiely D.K., Bird E.D., Williams R.S., Myers R.H. Morphometric analysis of the prefrontal cortex in Huntington's disease. Neurology 1991, 41(7):1117-1123.
53. Styner M., Brechbuhler C., Szekely G., Gerig G. Parametric estimate of intensity inhomogeneities applied to MRI. IEEE Trans. Med. Imaging 2000, 19(3):153-155.
54. Tabrizi S.J., Langbehn D.R., Leavitt B.R., Roos R.A., Durr A., Craufurd D., et al. Biological and clinical manifestations of Huntington's disease in the longitudinal TRACK-HD study: cross-sectional analysis of baseline data. Lancet Neurol. 2009, 8(9):791-801.
55. Thu D.C., Oorschot D.E., Tippett L.J., Nana A.L., Hogg V.M., Synek B.J., et al. Cell loss in the motor and cingulate cortex correlates with symptomatology in Huntington's disease. Brain 2010, 133(Pt 4):1094-1110.
56. Wagster M.V., Hedreen J.C., Peyser C.E., Folstein S.E., Ross C.A. Selective loss of [3H]kainic acid and [3H]AMPA binding in layer VI of frontal cortex in Huntington's disease. Exp. Neurol. 1994, 127(1):70-75.
57. Winkler A.M., Kochunov P., Blangero J., Almasy L., Zilles K., Fox P.T., et al. Cortical thickness or grey matter volume? The importance of selecting the phenotype for imaging genetics studies. Neuroimage 2009, PubMed PMID: 20006715.